Kibdelone C
Kibdelone C is a hexacyclic tetrahydroxanthone natural product and anticancer agent with sub-nanomolar GI50 activity against human SR leukemia and SN12C renal carcinoma cell lines. Kibdelone C disrupts the actin cytoskeleton in human cancer cells, leading to cell contraction and actin stress fiber formation, without direct actin binding, actin polymerization effects, topoisomerase I/II inhibition, or DNA binding. Kibdelone C can be used for the research of leukemia, and renal cell carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 934464-79-6
- Formel: C29H28ClNO10
- Molecular Weight:585.99
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biologische Aktivität
Beschreibung
In Vitro
Chemical Information
-
CAS. Nr. 934464-79-6
-
Appearance Solid
-
Molecular Weight 585.99
-
Formel C29H28ClNO10
-
Color Light yellow to yellow
-
SMILES
OC1=C2C3=C(O)C(C(N(C(CCC)=C4Cl)C)=O)=C4C(O)=C3CCC2=C(C5=C1C(C6=C([C@H](C[C@@H]([C@@H]6O)O)O)O5)=O)OC
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protokoll
-
Protocol for Electrophoretic Mobility Shift Assay (EMSA)
Electrophoretic mobility shift assay detects protein-nucleic acid binding by incubating a labeled DNA or RNA probe with purified protein or cell extract, then separating free probe from slower-migrating protein-probe complexes on a native gel. For cancer cells, primary neurons, mouse tumor samples, intestinal organoids, inflammatory macrophages, or drug-treated samples, EMSA can measure transcription-factor DNA binding or RNA-binding protein activity in extracts, but it does not directly measure transcription, protein expression, or chromatin occupancy in intact cells. Specificity is judged by competition with unlabeled wild-type probe, failure of mutated or unrelated competitors to compete, and antibody supershift or disruption when the binding protein identity must be confirmed.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
Reinheit & Dokumentation
-
Data Sheet (270 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Sloman DL, et al. Total synthesis and absolute stereochemical assignment of kibdelone C. J Am Chem Soc. 2011;133(26):9952-9955. [Content Brief]
[2]. Rujirawanich J, et al. Synthesis and Biological Evaluation of Kibdelone C and Its Simplified Derivatives. J Am Chem Soc. 2016;138(33):10561-10570. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Kibdelone C
- 934464-79-6
- Drug Derivative
- human SR leukemia cell lines
- SN12C renal carcinoma cell lines
- HCT116 human colon cancer cells
- H2122 human non-small cell lung cancer cells
- HeLa human cervical cancer cells
- renal cell carcinoma
- leukemia
- H157 human non-small cell lung cancer cells
- H2073 human non-small cell lung cancer cells
- actin cytoskeleton
- Inhibitor
- inhibitor
- inhibit